Specific inhibition of oncogene expression in vitro and in vivo by antisense oligonucleotides.
Neckers
L
L
Clinical Pharmacology Branch, National Institutes of Health, National Cancer Institute, Bethesda, Maryland 20892.
Rosolen
A
A
Fahmy
B
B
Whitesell
L
L
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D016373:DNA, Antisense / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects*; D016259:Genes, myc / Q000235:genetics*; D051379:Mice; D009423:Nervous System Neoplasms; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D011519:Proto-Oncogenes; D016372:RNA, Antisense / Q000494:pharmacology; D013234:Stem Cells / Q000187:drug effects; D014407:Tumor Cells, Cultured
D016373:DNA, Antisense; D016376:Oligonucleotides, Antisense; D016372:RNA, Antisense